Welcome to our dedicated page for Dorman Products SEC filings (Ticker: DORM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Dorman Products's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Dorman Products's regulatory disclosures and financial reporting.
Dorman Products, Inc. (DORM) filed a Form 144 disclosing a planned discretionary sale by an affiliate/insider of 820 common shares—valued at approximately $100,040—through Fidelity Brokerage Services on or about 28 July 2025. The stake equals roughly 0.003 % of the company’s 30,511,174 shares outstanding and therefore is immaterial to float and daily trading volume.
The shares originated from restricted-stock vesting on 6 Mar 2022 and constitute non-cash compensation. The filer reports no other sales in the prior three months and certifies lack of undisclosed adverse information. While insider transactions can signal sentiment, the modest dollar amount and percentage suggest limited market impact.